Related references
Note: Only part of the references are listed.Data sources for drug utilization research in Latin American countries-A cross-national study: DASDUR-LATAM study
Luciane C. Lopes et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2022)
Data Sources for Drug Utilization Research in Brazil-DUR-BRA Study
Lisiane Freitas Leal et al.
FRONTIERS IN PHARMACOLOGY (2022)
Age-related macular degeneration and resource utilization in the Brazilian public healthcare system: a real-world retrospective study
Liane Touma-Falci et al.
BMC OPHTHALMOLOGY (2021)
Recommendations of the Brazilian Society of Rheumatology for the use of JAK inhibitors in the management of rheumatoid arthritis
Karina Rossi Bonfiglioli et al.
ADVANCES IN RHEUMATOLOGY (2021)
Operational Challenges in the Use of Structured Secondary Data for Health Research
Kelsy N. Areco et al.
FRONTIERS IN PUBLIC HEALTH (2021)
The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review
Khalid Almutairi et al.
RHEUMATOLOGY INTERNATIONAL (2021)
Annualized hospitalization rate with natalizumab vs fingolimod in second-line treatment for RRMS in the public healthcare system in Brazil: A claim database approach
Guilherme Silva Julian et al.
PLOS ONE (2020)
Rheumatoid artrhitis treatment in Brazil: data from a large real-life multicenter study
Ana Paula Monteiro Gomides et al.
ADVANCES IN RHEUMATOLOGY (2020)
Real-World Evidence in Healthcare Decision Making: Global Trends and Case Studies From Latin America
Nahila Justo et al.
VALUE IN HEALTH (2019)
Preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs: a discrete choice experiment
Milou van Heuckelum et al.
PATIENT PREFERENCE AND ADHERENCE (2019)
Pathway Based Analysis of Mutation Data Is Efficient for Scoring Target Cancer Drugs
Marianna A. Zolotovskaia et al.
FRONTIERS IN PHARMACOLOGY (2019)
Real-World Evidence and Real-World Data for Evaluating Drug Safety and Effectiveness
Jacqueline Corrigan-Curay et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
An overview of Phoneutria nigriventer spider venom using combined transcriptomic and proteomic approaches
Marcelo R. Diniz et al.
PLOS ONE (2018)
Evaluation study of the National Immunization Program Information System
Brener Santos Silva et al.
REVISTA BRASILEIRA DE ENFERMAGEM (2018)
The REAL study: a nationwide prospective study of rheumatoid arthritis in Brazil
Geraldo da Rocha Castelar-Pinheiro et al.
ADVANCES IN RHEUMATOLOGY (2018)
Treatment patterns, health care resource utilization and costs of rheumatoid arthritis patients in Italy: findings from a retrospective administrative database analysis
Walid Fakhouri et al.
OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS (2018)
Real world data: an opportunity to supplement existing evidence for the use of long-established medicines in health care decision making
Vaibhav B. Katkade et al.
JOURNAL OF MULTIDISCIPLINARY HEALTHCARE (2018)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Clinical Outcomes and Biologic Costs of Switching Between Tumor Necrosis Factor Inhibitors in US Veterans with Rheumatoid Arthritis
Grant W. Cannon et al.
ADVANCES IN THERAPY (2016)
Ten-year kidney transplant survival of cyclosporine- or tacrolimus-treated patients in Brazil
Rosangela Maria Gomes et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2016)
Survival on treatment with second-line biologic therapy: a cohort study comparing cycling and swap strategies
Ennio Giulio Favalli et al.
RHEUMATOLOGY (2014)
Genetic services and testing in Brazil
Dafne Dain Gandelman Horovitz et al.
JOURNAL OF COMMUNITY GENETICS (2013)
Patterns of biologic agent utilization among patients with rheumatoid arthritis: a retrospective cohort study
Sarika Ogale et al.
BMC MUSCULOSKELETAL DISORDERS (2011)
Management of rheumatoid diseases: the Brazilian perspective
Fernando S. Cavalcanti
RHEUMATOLOGY (2010)